Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-14-032227
Filing Date
2014-09-17
Accepted
2014-09-17 17:12:14
Documents
1
Period of Report
2014-09-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 - LAWRENCE P. WENNOGLE, PH.D. rrd416265.html 4  
1 FORM 4 - LAWRENCE P. WENNOGLE, PH.D. rrd416265.xml 4 3212
  Complete submission text file 0001181431-14-032227.txt   4678
Mailing Address 3960 BROADWAY NEW YORK NY 10032
Business Address 3960 BROADWAY NEW YORK NY 10032 212-923-3344
Intra-Cellular Therapies, Inc. (Issuer) CIK: 0001567514 (see all company filings)

EIN.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INTRA-CELLULAR THERAPIES, INC. 3960 BROADWAY NEW YORK NY 10032
Business Address
Wennogle Lawrence P. (Reporting) CIK: 0001585663 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36274 | Film No.: 141108553